MedTrace Logo

An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.

NCT04921735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-01-26

No results posted yet for this study

Summary

The aim of this study is to determine the onset time, duration of action and effect on intubation conditions of cisatracurium 0.15 mg/kg in elderly patients with age ≥ 80 years and in young patients aged 18 - 40 years.

Conditions

  • Onset Time of Cisatracurium
  • Duration of Action of Cisatracurium
  • Intubation Conditions

Interventions

DRUG

Cisatracurium

0.15 mg/kg based on ideal body weight calculated as height (cm) minus 105 for women and height (cm) minus 100 for men or actual body weight, whichever is lower

Sponsors & Collaborators

  • Matias Vested

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-05
Primary Completion
2021-12-19
Completion
2021-12-19
FDA Drug
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04921735 on ClinicalTrials.gov